tradingkey.logo

AtriCure Inc

ATRC
View Detailed Chart
40.330USD
-0.220-0.54%
Close 12/26, 16:00ETQuotes delayed by 15 min
2.00BMarket Cap
LossP/E TTM

AtriCure Inc

40.330
-0.220-0.54%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.54%

5 Days

-1.51%

1 Month

+11.93%

6 Months

+22.66%

Year to Date

+31.97%

1 Year

+31.15%

View Detailed Chart

TradingKey Stock Score of AtriCure Inc

Currency: USD Updated: 2025-12-26

Key Insights

AtriCure Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 51.67.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

AtriCure Inc's Score

Industry at a Glance

Industry Ranking
12 / 207
Overall Ranking
74 / 4563
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 9 analysts
Buy
Current Rating
51.667
Target Price
+32.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

AtriCure Inc Highlights

StrengthsRisks
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 40.84% year-on-year.
Undervalued
The company’s latest PE is -66.36, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.59M shares, decreasing 0.21% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 28.64K shares of this stock.

AtriCure Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

AtriCure Inc Info

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Ticker SymbolATRC
CompanyAtriCure Inc
CEOCarrel (Michael H)
Websitehttps://www.atricure.com

FAQs

What is the current price of AtriCure Inc (ATRC)?

The current price of AtriCure Inc (ATRC) is 40.330.

What is the symbol of AtriCure Inc?

The ticker symbol of AtriCure Inc is ATRC.

What is the 52-week high of AtriCure Inc?

The 52-week high of AtriCure Inc is 43.110.

What is the 52-week low of AtriCure Inc?

The 52-week low of AtriCure Inc is 28.290.

What is the market capitalization of AtriCure Inc?

The market capitalization of AtriCure Inc is 2.00B.

What is the net income of AtriCure Inc?

The net income of AtriCure Inc is -44.70M.

Is AtriCure Inc (ATRC) currently rated as Buy, Hold, or Sell?

According to analysts, AtriCure Inc (ATRC) has an overall rating of Buy, with a price target of 51.667.

What is the Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC)?

The Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC) is -0.608.
KeyAI